nominally significantP < 0.01
While cytokine pathway signal differs by treatment, all tested prioritized candidates—except RGS14 —show nominally significant ( t test, P < 0.01) signal in at least one treatment condition (Supplementary Fig. 9b ).
While cytokine pathway signal differs by treatment, all tested prioritized candidates—except RGS14 —show nominally significant ( t test, P < 0.01) signal in at least one treatment condition (Supplementary Fig. 9b ).